CINXE.COM

HFP FOIA Electronic Reading Room | FDA

<!DOCTYPE html> <html lang="en" dir="ltr" prefix="og: https://ogp.me/ns#"> <head> <meta charset="utf-8" /> <script async src="https://www.googletagmanager.com/gtag/js?id=G-273DTKB5QW"></script> <meta name="description" content="The HFP Electronic Reading Room displays copies of HFP records." /> <meta name="dcterms.title" content="HFP FOIA Electronic Reading Room" /> <meta name="dcterms.creator" content="Human Foods Program" /> <meta name="dcterms.description" content="The HFP Electronic Reading Room displays copies of HFP records." /> <meta name="dcterms.publisher" content="FDA" /> <meta name="dcterms.source" content="FDA" /> <meta property="og:site_name" content="U.S. Food and Drug Administration" /> <meta property="og:type" content="Article" /> <meta property="og:url" content="https://www.fda.gov/about-fda/human-foods-program/hfp-foia-electronic-reading-room" /> <meta property="og:title" content="HFP FOIA Electronic Reading Room" /> <meta property="og:updated_time" content="Tue, 10/01/2024 - 10:00" /> <meta property="article:published_time" content="Tue, 10/15/2024 - 09:16" /> <meta property="article:modified_time" content="Tue, 10/01/2024 - 10:00" /> <meta name="google-site-verification" content="tWxlDhm4ANdksJZPj7TBmHgNoMqZCnecPp0Aa2vC9XA" /> <meta name="twitter:card" content="summary_large_image" /> <meta name="twitter:site" content="@US_FDA" /> <meta name="twitter:title" content="HFP FOIA Electronic Reading Room" /> <meta name="twitter:creator" content="@US_FDA" /> <meta name="MobileOptimized" content="width" /> <meta name="HandheldFriendly" content="true" /> <meta name="viewport" content="width=device-width, initial-scale=1.0" /> <script type="application/ld+json">{ "@context": "https://schema.org", "@graph": [ { "@type": "Article", "headline": "HFP FOIA Electronic Reading Room", "name": "HFP FOIA Electronic Reading Room", "description": "The HFP Electronic Reading Room displays copies of HFP records.", "datePublished": "Tue, 10/15/2024 - 09:16", "dateModified": "Tue, 10/01/2024 - 10:00", "author": { "@type": "Organization", "name": "Human Foods Program" }, "publisher": { "@type": "Organization", "name": "FDA" } } ] }</script> <meta property="og:image" content="https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png" /> <meta name="twitter:image" content="https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png" /> <meta property="og:description" content="The HFP Electronic Reading Room displays copies of HFP records." /> <meta property="twitter:description" content="The HFP Electronic Reading Room displays copies of HFP records." /> <link rel="icon" href="/themes/custom/preview/favicon.ico" type="image/vnd.microsoft.icon" /> <link rel="alternate" hreflang="en" href="https://www.fda.gov/about-fda/human-foods-program/hfp-foia-electronic-reading-room" /> <link rel="canonical" href="https://www.fda.gov/about-fda/human-foods-program/hfp-foia-electronic-reading-room" /> <link rel="shortlink" href="https://www.fda.gov/node/359629" /> <script src="/files/google_tag/production/google_tag.script.js?smgeuw" defer></script> <title>HFP FOIA Electronic Reading Room | FDA</title> <link rel="stylesheet" media="all" href="/files/css/css_nIAEFYPN7y_O0y9dA__6_ZBSGy8omYOK6rvMeZ1warY.css?delta=0&amp;language=en&amp;theme=preview&amp;include=eJxljlEOwjAMQy_UUX6QuE2VtVmpaOuqCUPj9DAQA8FP5NiS_SZUpSsLCtvpo3cmAjGzo0p50eTF_hpGFlEudiRh0zrPia82ZoyUB9Elpxr_bN9TUzEjoKKdmm1omLmbKZDzZw5J0R3XE1XPhauKJe_RQ0J1irgCyAldPQKbtVrs8-4KwiXzqwel5bQ2vDJ32B-_TDM91iuUxW5qA_WdbgvHD3mg9tx6_9v6sIHdAfkmf6A" /> <link rel="stylesheet" media="all" href="/files/css/css_xLeUZALg1CD0YmiSIzZnqkwKfNF_g3TkAjkxBt_uccA.css?delta=1&amp;language=en&amp;theme=preview&amp;include=eJxljlEOwjAMQy_UUX6QuE2VtVmpaOuqCUPj9DAQA8FP5NiS_SZUpSsLCtvpo3cmAjGzo0p50eTF_hpGFlEudiRh0zrPia82ZoyUB9Elpxr_bN9TUzEjoKKdmm1omLmbKZDzZw5J0R3XE1XPhauKJe_RQ0J1irgCyAldPQKbtVrs8-4KwiXzqwel5bQ2vDJ32B-_TDM91iuUxW5qA_WdbgvHD3mg9tx6_9v6sIHdAfkmf6A" /> <script src="https://script.crazyegg.com/pages/scripts/0024/3700.js" async></script> <script src="https://dap.digitalgov.gov/Universal-Federated-Analytics-Min.js?agency=HHS&amp;subagency=FDA&amp;sdor=fda.gov&amp;dclink=true" language="javascript" id="_fed_an_ua_tag"></script> <script>window.dataLayer = window.dataLayer || [];function gtag(){dataLayer.push(arguments)};gtag("js", new Date());gtag("set", "developer_id.dMDhkMT", true);gtag("config", "G-273DTKB5QW", {"groups":"default","page_placeholder":"PLACEHOLDER_page_location","allow_ad_personalization_signals":false});</script> </head> <body class="role-anonymous path-node page-node-type-sub-section has-glyphicons"> <div id="quicklinks" class="sr-only"> <ul> <li><a href="#main-content" class="sr-only sr-only-focusable" tabindex="1">Skip to main content</a></li> <li><a href="#search-form" class="sr-only sr-only-focusable" tabindex="1">Skip to FDA Search</a></li> <li><a href="#section-nav" class="sr-only sr-only-focusable" tabindex="1">Skip to in this section menu</a></li> <li><a href="#footer-heading" class="sr-only sr-only-focusable" tabindex="1">Skip to footer links</a></li> </ul> </div> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-M95XGZW" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas> <div class="main-container container-fluid"> <div class="row"> <header class="lcds-header container-fluid" role="heading" aria-level="1"> <div class="row us-masthead"> <div class="usa-banner col-xs-12"> <img class="usa-banner__us-flag" src="/themes/custom/preview/assets/images/US_Flag.png" alt="U.S. flag" /> <span>An official website of the United States government</span> <a id="USMenuButton" class="collapsed" data-toggle="collapse" data-target="#USABannerMenu" aria-controls="USABannerMenu">Here’s how you know <span class="toggle-indicator"> </span></a> <div class="col-xs-12 collapse usa-banner__menu" id="USABannerMenu" aria-labelledby="USMenuButton"> <div id="gov-banner" class="row usa-banner-content usa-grid usa-accordion-content" aria-hidden="true"> <div class="col-xs-12 col-sm-6 col-md-3"> <img class="usa-banner-icon usa-media_block-img" src="/themes/custom/preview/assets/images/icon-dot-gov.svg" alt="Dot gov" style="width:3em;"> <div class="usa-media_block-body"> <p><strong>The .gov means it’s official.</strong><br>Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.</p> </div> </div> <div class="col-xs-12 col-sm-6 col-md-3"> <img class="usa-banner-icon usa-media_block-img" src="/themes/custom/preview/assets/images/icon-https.svg" alt="SSL" style="width:3em;"> <div class="usa-media_block-body"> <p><strong>The site is secure.</strong><br> The <strong>https://</strong> ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.</p> </div> </div> </div> </div> </div> </div> <div class="alert alert-warning margin-left-neg-2 margin-right-neg-2 margin-top-3 margin-bottom-1"> <p>On Oct. 1, 2024, the FDA began implementing a <a href="/about-fda/fda-organization/fda-modernization-efforts-establishing-unified-human-foods-program-new-model-field-operations-and" title="FDA Modernization Efforts for Establishing a Unified Human Foods Program, New Model for Field Operations and More">reorganization</a> impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.</p> </div> <div class="row fda-masthead"> <div class="col-xs-4 col-md-8"> <a href="/" title="FDA Homepage"> <h1 class="fda-masthead__fda-logo">U.S. Food and Drug Administration</h1> </a> </div> <div class="col-xs-8 col-md-4"> <ul class='fda-masthead__item-list'> <li><a title="" id="btn-search" class="btn btn-default btn-sm fda-masthead__btn-search"> <span class="fa fa-search" aria-hidden="true">&nbsp;</span> <span class="fda-masthead__btn-label">Search</span> </a></li> <li><a id="menu-btn" class="btn btn-default btn-sm fda-masthead__btn-menu collapsed" href="#primary-nav" data-toggle="collapse" aria-expanded="true"> <span class="fa fa-bars" aria-hidden="true">&nbsp;</span> <span class='fda-masthead__btn-label'>Menu</span> </a></li> </ul> </div> <form class="fda-masthead__search sr-only" role="search" action="/search" method="GET" name="searchForm" id="search-form" accept-charset="UTF-8" > <div class="search-popover" id="search-popover"> <div class="input-group pull-right" id="search-group"> <label class="sr-only" for="search-query">Search FDA</label> <input class="form-control search-input" id="search-query" name="s" aria-autocomplete="list" aria-haspopup="true" title="Enter the terms you wish to search for." placeholder="Search FDA" type="text" /> <span class="input-group-btn" id="input-group-btn"> <button type="submit" class="btn btn-danger search-btn" id="search-btn" title="Search"><span class="fa fa-search" aria-hidden="true"><span class="sr-only">Submit search</span></span></button> </span> </div> </div> </form> </div> <nav id="primary-nav" class="lcds-primary-nav row collapse"> <div class="col-md-5 col-lg-4"> <section class="lcds-primary-nav__group lcds-primary-nav__group--bordered"> <h2 class="lcds-primary-nav__group-heading">Featured</h2> <ul class="lcds-primary-nav__list lcds-primary-nav__list--featured"> <li class="lcds-primary-nav__list-item"><a href="https://www.safetyreporting.hhs.gov/smarthub#/" title="Report a Problem with an FDA Regulated Product">Report a Product Problem</a></li> <li class="lcds-primary-nav__list-item"><a href="/about-fda/contact-fda">Contact FDA</a></li> <li class="lcds-primary-nav__list-item"><a href="/regulatory-information/search-fda-guidance-documents">FDA Guidance Documents</a></li> <li class="lcds-primary-nav__list-item"><a href="/safety/recalls-market-withdrawals-safety-alerts">Recalls, Market Withdrawals and Safety Alerts</a></li> <li class="lcds-primary-nav__list-item"><a href="/news-events/newsroom/press-announcements">Press Announcements</a></li> <li class="lcds-primary-nav__list-item"><a href="/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters">Warning Letters</a></li> <li class="lcds-primary-nav__list-item"><a href="/advisory-committees">Advisory Committees</a></li> <li class="lcds-primary-nav__list-item"><a href="/fda-en-espanol">En Espa&#241ol</a></li> </ul> </section> </div> <div class="col-md-7 col-lg-8"> <section class="lcds-primary-nav__group lcds-primary-nav__group--bordered"> <h2 class="lcds-primary-nav__group-heading">Products</h2> <ul class="lcds-primary-nav__list"> <li class="lcds-primary-nav__list-item"><a href="/food">Food</a></li> <li class="lcds-primary-nav__list-item"><a href="/drugs">Drugs</a></li> <li class="lcds-primary-nav__list-item"><a href="/medical-devices">Medical Devices</a></li> <li class="lcds-primary-nav__list-item"><a href="/radiation-emitting-products">Radiation-Emitting Products</a></li> <li class="lcds-primary-nav__list-item"><a href="/vaccines-blood-biologics">Vaccines, Blood, and Biologics</a></li> <li class="lcds-primary-nav__list-item"><a href="/animal-veterinary">Animal and Veterinary</a></li> <li class="lcds-primary-nav__list-item"><a href="/cosmetics">Cosmetics</a></li> <li class="lcds-primary-nav__list-item"><a href="/tobacco-products">Tobacco Products</a></li> </ul> </section> <section class="lcds-primary-nav__group lcds-primary-nav__group--bordered"> <h2 class="lcds-primary-nav__group-heading">Topics</h2> <ul class="lcds-primary-nav__list"> <li class="lcds-primary-nav__list-item"><a href="/about-fda">About FDA</a></li> <li class="lcds-primary-nav__list-item"><a href="/combination-products">Combination Products</a></li> <li class="lcds-primary-nav__list-item"><a href="/regulatory-information">Regulatory Information</a></li> <li class="lcds-primary-nav__list-item"><a href="/safety">Safety</a></li> <li class="lcds-primary-nav__list-item"><a href="/emergency-preparedness-and-response">Emergency Preparedness</a></li> <li class="lcds-primary-nav__list-item"><a href="/international-programs">International Programs</a></li> <li class="lcds-primary-nav__list-item"><a href="/news-events">News and Events</a></li> <li class="lcds-primary-nav__list-item"><a href="/training-and-continuing-education">Training and Continuing Education</a></li> <li class="lcds-primary-nav__list-item"><a href="/inspections-compliance-enforcement-and-criminal-investigations">Inspections and Compliance</a></li> <li class="lcds-primary-nav__list-item"><a href="/science-research">Science and Research</a></li> </ul> </section> <section class="lcds-primary-nav__group lcds-primary-nav__group--bordered"> <h2 class="lcds-primary-nav__group-heading">Information For</h2> <ul class="lcds-primary-nav__list"> <li class="lcds-primary-nav__list-item"><a href="/consumers">Consumers</a></li> <li class="lcds-primary-nav__list-item"><a href="/patients">Patients</a></li> <li class="lcds-primary-nav__list-item"><a href="/industry">Industry</a></li> <li class="lcds-primary-nav__list-item"><a href="/health-professionals">Health Professionals</a></li> <li class="lcds-primary-nav__list-item"><a href="/federal-state-local-tribal-and-territorial-officials">Federal, State and Local Officials</a></li> </ul> </section> </div> </nav> </header> <div class="col-xs-12"> <div data-drupal-messages-fallback class="hidden"></div> </div> <section id="block-entityviewcontent" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix"> <a class="lcds-button--expandable collapsed hidden-md hidden-lg" data-toggle="collapse" href="#section-nav">In this section<span class="visible-sm-inline-block">: Human Foods Program </span> </a> <nav id="section-nav" class="lcds-card lcds-section-nav lcds-section-nav hidden-md hidden-lg collapse"> <ul class="lcds-section-nav__list"> <li> <a href="/about-fda/human-foods-program/hfp-foia-electronic-reading-room" class="lcds-section-nav__section-link lcds-section-nav__link lcds-section-nav__parent-link">HFP FOIA Electronic Reading Room</a> <div class="views-element-container form-group"><div class="view view-in-this-section view-id-in_this_section view-display-id-block_5 js-view-dom-id-bb70e196738ed4e01043dfd95fef81b84a063a5dec1ab63d60c3419bab6a7c3c"> </div> </div> <div class="views-element-container form-group"><div class="view view-in-this-section-sub view-id-in_this_section_sub view-display-id-block_2 js-view-dom-id-b633a3e31bd8ee1f84d2f8e7dcc33ce5a81c8e012203fc2b9db4cfac216ab70a"> </div> </div> </li> </ul> </nav> </section> <section id="block-entityviewcontent-15" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix"> <ol class="lcds-breadcrumb visible-md visible-lg"> <li > <a href="/">Home</a> </li> <li > <a href="/about-fda">About FDA</a> </li> <li > <a href="/about-fda/fda-organization">FDA Organization</a> </li> <li > <a href="/about-fda/fda-organization/human-foods-program">Human Foods Program</a> </li> <li > <a class="current-link">HFP FOIA Electronic Reading Room</a> </li> </ol> <ol class="lcds-breadcrumb visible-sm visible-xs"> <li> <a href="/about-fda/fda-organization/human-foods-program" title="Human Foods Program"> Human Foods Program </a> </li> </ol> </section> <main> <article id="main-content" class="article main-content container-fluid" role="article"> <header class="row content-header" role="heading" aria-level="1"> <section id="block-entityviewcontent-14" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix"> <div class="col-sm-12 col-md-8 col-md-offset-2"> <h1 class="content-title text-center">HFP FOIA Electronic Reading Room</h1> <div class="lcds-toolbar lcds-toolbar--social"> <ul class="lcds-share lcds-share--default"> <li class="lcds-share__item"> <a href="https://www.facebook.com/sharer/sharer.php?u=https://www.fda.gov%2Fabout-fda%2Fhuman-foods-program%2Fhfp-foia-electronic-reading-room" class="lcds-share__btn lcds-share--default__btn-facebook js-share" id="fb-share" target="_blank"><span class="fa icon-facebook" aria-hidden="true"></span>Share</a> </li> <li class="lcds-share__item"> <a href="https://x.com/intent/tweet/?text=HFP%20FOIA%20Electronic%20Reading%20Room&amp;url=https://www.fda.gov%2Fabout-fda%2Fhuman-foods-program%2Fhfp-foia-electronic-reading-room" target="_blank" class="lcds-share__btn lcds-share--default__btn-x-twitter js-share" id="twitter-share"> <svg class="icon-svg-inline" aria-hidden="true"> <use href="/themes/custom/preview/assets/images/fa-icons.svg#icon-x-twitter"> </svg> Post </a> </li> <li class="lcds-share__item hidden-xs"> <a href="https://www.linkedin.com/shareArticle?mini=true&amp;url=https://www.fda.gov%2Fabout-fda%2Fhuman-foods-program%2Fhfp-foia-electronic-reading-room&amp;title=HFP%20FOIA%20Electronic%20Reading%20Room&amp;source=FDA" class="lcds-share__btn lcds-share--default__btn-linkedin js-share" id="linkedin-share" target="_blank"><span class="fa icon-linkedin" aria-hidden="true"></span>Linkedin</a> </li> <li class="lcds-share__item"> <a href="mailto:?subject=HFP%20FOIA%20Electronic%20Reading%20Room&amp;body=https://www.fda.gov%2Fabout-fda%2Fhuman-foods-program%2Fhfp-foia-electronic-reading-room" class="lcds-share__btn lcds-share--default__btn-mail"><span class="fa icon-envelope" aria-hidden="true"></span>Email</a> </li> <li class=" lcds-share__item hidden-xs"> <a href="javascript:window.print();" title="Print this page" class="lcds-share__btn lcds-share--default__btn-print"><span class="fa icon-print" aria-hidden="true"></span>Print</a> </li> </ul> <div class="form-group"> </div> </div> </div> </section> </header> <div class="col-md-8 col-md-push-2" role="main"> <div class="inset-column"> <p>The&nbsp;HFP Electronic Reading Room displays copies of&nbsp;HFP records. We are making these records publicly available either (1) proactively at our discretion or (2) because they are "frequently requested" per the Electronic Freedom of Information Act Amendments of 1996. Some records may be redacted to remove non-public information (see 21 CFR Part 20).</p> <p><strong>Resources</strong></p> <ul> <li><a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="aa8b1b55-ca8b-4c71-b28f-45e98152b87c" href="/regulatory-information/freedom-information" target title="Freedom of Information">FDA Freedom of Information (FOI)</a></li> <li><a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="b0c0096a-7b62-4aee-aa35-295b3e0cbd30" href="/regulatory-information/freedom-information/how-make-foia-request" target title="How to Make a FOIA Request">How to Make a FOIA Request</a></li> <li><a href="https://www.hhs.gov/web/governance/digital-strategy/it-policy-archive/hhs-ocio-policy-for-records-management.html">HHS Policy for Records Management</a></li> <li><a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="62fae505-06da-4e40-980c-835788ea4ecd" href="/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters" target title="Warning Letters">FDA Warning Letters</a></li> <li><a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="2bed20ee-0f97-415f-b7ef-f94e855d53b0" href="/food/guidance-regulation-food-and-dietary-supplements/guidance-documents-regulatory-information-topic-food-and-dietary-supplements" target title="Guidance Documents &amp; Regulatory Information by Topic (Food and Dietary Supplements)">Food Guidance Documents </a></li> <li><a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="8d358f3e-fcb2-40f4-9152-c57f8314b7f9" href="/inspections-compliance-enforcement-and-criminal-investigations/compliance-manuals/compliance-program-manual" target title="Compliance Program Manual ">Compliance Program Guidance Manual (CPGM) </a></li> <li><a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="b7332514-27c4-4653-8ab3-db29150c47af" href="/regulatory-information/dockets-management" target title="Dockets Management">Dockets Management</a></li> </ul> <div id="right_col_box2" panel-default> <hr> <h2>Electronic Reading Room Postings</h2> <p>Note:The FDA reached a significant milestone with approval of its <a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="d6d0e689-47db-4dcb-b41c-f763a7c3425d" href="/about-fda/fda-organization/fda-modernization-efforts-establishing-unified-human-foods-program-new-model-field-operations-and" title="FDA Modernization Efforts for Establishing a Unified Human Foods Program, New Model for Field Operations and More">reorganization</a>&nbsp;involving the creation of a unified Human Foods Program (HFP), adoption of a new model for its field operations, and other significant modernization efforts. The reorganization went into effect on October 1, 2024.&nbsp;The reorganization established the HFP by realigning the functions of the Center for Food Safety and Applied Nutrition (CFSAN), the Office of Food Policy and Response (OFPR), as well as key functions from the Office of Regulatory Affairs (ORA) under one program.</p> <div title="Posted 2024" open="yes" class=" panel panel-default fda-accordion-panel"> <div class="panel-heading" role="tab" id="heading_6746b94bb8063"> <h2 class="panel-title"> <a role="button" data-toggle="collapse" data-parent href="#6746b94bb8063" aria-controls="6746b94bb8063">Posted 2024</a> </h2> </div> <div id="6746b94bb8063" class="panel-collapse collapse in" role="tabpanel" aria-labelledby="heading_6746b94bb8063"> <div class="panel-body"> <ul> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="ef1bcc69-e8c3-4638-a2b6-14a58aef12fc" href="/media/182122/download?attachment" hreflang="en" title="FDA Memo: An evaluation of the article “The artificial sweetener erythritol and cardiovascular event risk” by Witkowski et al., Nat Med. 2023 Mar;29(3):710-718.">FDA Memo: An evaluation of the article “The artificial sweetener erythritol and cardiovascular event risk” by Witkowski et al., Nat Med. 2023 Mar;29(3):710-718./media-base/182122</a> - (PDF - 523KB) June 2023</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="de4f4c9d-eaf6-49e2-a344-0a26819b33b3" href="/media/179194/download?attachment" title="FDA Open Letter to State Regulatory Partners Regarding HPAIV and Intrastate Raw Milk Recommendations - June 6, 2024">FDA Open Letter to State Regulatory Partners Regarding HPAIV and Intrastate Raw Milk Recommendations</a> - (PDF - 216KB) June 2024</li> </ul> </div> </div> </div> <div title="Posted 2023" open="yes" class=" panel panel-default fda-accordion-panel"> <div class="panel-heading" role="tab" id="heading_6746b94bb8c22"> <h2 class="panel-title"> <a role="button" data-toggle="collapse" data-parent href="#6746b94bb8c22" aria-controls="6746b94bb8c22">Posted 2023</a> </h2> </div> <div id="6746b94bb8c22" class="panel-collapse collapse in" role="tabpanel" aria-labelledby="heading_6746b94bb8c22"> <div class="panel-body"> <ul> <li>CFSAN Cadmium Memorandum Letters (Roasted Organic Seaweed Snack &amp; Bugak Seaweed Chips) November 2022 <ul> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="d28a443e-840a-40ee-bc95-62c8f85c725e" href="/media/173150/download?attachment" title="CFSAN Cadmium Memorandum Letter (Bugak Seaweed Chips - Case# 645290) November 2, 2022">CFSAN Cadmium Memorandum Letter&nbsp;(Bugak Seaweed Chips - Case# 645290) - November 2, 2022</a> - (PDF - 249KB)</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="3efa1619-2f16-4680-ac6b-87a620fe9768" href="/media/173151/download?attachment" title="CFSAN Cadmium Memorandum Letter (Bugak Seaweed Chips - Case# 645358) November 3, 2022">CFSAN Cadmium Memorandum Letter&nbsp;(Bugak Seaweed Chips - Case# 645358) - November 3, 2022</a> - (PDF - 250KB)</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="3db1e41d-2b20-46f3-9efd-6593bdc8f947" href="/media/173152/download?attachment" title="CFSAN Cadmium Memorandum Letter (Roasted Organic Seaweed Snack - Case# 645292) November 21, 2022">CFSAN Cadmium Memorandum Letter&nbsp;(Roasted Organic Seaweed Snack - Case# 645292) - November 21, 2022</a> - (PDF - 246KB)</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="248d8b57-9d90-4270-beb2-2b999d8c40f8" href="/media/173153/download?attachment" title="CFSAN Cadmium Memorandum Letter (Roasted Organic Seaweed Snack - Case# 645986) November 21, 2022">CFSAN Cadmium Memorandum Letter&nbsp;(Roasted Organic Seaweed Snack - Case# 645986) - November 21, 2022</a> - (PDF - 246KB)</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="d8bcc6b4-5ba6-44cb-9371-bc41c87e9d6b" href="/media/173154/download?attachment" title="CFSAN Cadmium Memorandum Letter (Roasted Organic Seaweed Snack - Cases# 646463 &amp; 646470) November 28, 2022">CFSAN Cadmium Memorandum Letter&nbsp;(Roasted Organic Seaweed Snack - Cases# 646463 &amp; 646470) - November 28, 2022</a> - (PDF - 274KB)</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="bc4aee6d-f8df-4857-ad3b-74e1def83889" href="/media/173155/download?attachment" title="CFSAN Cadmium Memorandum Letter (Roasted Organic Seaweed Snack - Case# 646768) November 29, 2022">CFSAN Cadmium Memorandum Letter&nbsp;(Roasted Organic Seaweed Snack - Case# 646768) - November 29, 2022</a> - (PDF - 246KB)</li> </ul> </li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="cd5efd90-38ab-400a-a0fa-950845a04d7c" href="/media/173048/download?attachment" title="CFSAN Adverse Event Reporting System: EVIVO MCT Oil Infant Death (April 27, 2023)">CFSAN Adverse Event Reporting System: EVIVO MCT oil Infant Death - April 27, 2023</a>&nbsp;- (PDF - 120KB)</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="c4e2801a-d282-4aee-a727-8bd16817110d" href="/media/166750/download?attachment" title="Adverse Illness Event Series/Lentil and Leek Crumbles/Jun 2022 Incident Summary Report">Adverse Illness Event Series/Lentil and Leek Crumbles/Jun 2022 Incident Summary Report - October 18, 2022</a>&nbsp;(PDF - 15MB)</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="d3b1ec11-0016-45a0-8e41-a98a07153c86" href="/media/166751/download?attachment" title="CFSAN Health Hazard Evaluation #10408 (August 3, 2020)">CFSAN Health Hazard Evaluation #10408 - August 3, 2020</a>&nbsp;(PDF - 11MB)&nbsp;</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="65a0f3d7-277a-46da-bf63-e633e18e2c27" href="/media/166752/download?attachment" title="Salmonella Senftenberg Peanut Butter (May 2022)">Salmonella Senftenberg Peanut Butter - May 2022</a>&nbsp;(PDF - 11MB)&nbsp;</li> </ul> </div> </div> </div> <div title="Posted 2022" open="yes" class=" panel panel-default fda-accordion-panel"> <div class="panel-heading" role="tab" id="heading_6746b94bb8cd6"> <h2 class="panel-title"> <a role="button" data-toggle="collapse" data-parent href="#6746b94bb8cd6" aria-controls="6746b94bb8cd6">Posted 2022</a> </h2> </div> <div id="6746b94bb8cd6" class="panel-collapse collapse in" role="tabpanel" aria-labelledby="heading_6746b94bb8cd6"> <div class="panel-body"> <ul> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="746563c1-15fe-4128-805d-9c8773940fe4" href="/media/163568/download?attachment" title="AMA Testing of Official Samples of Talc Containing Cosmetics for Asbestiform Fibers - Assignment DFPG# 22-08, Batch No. 01212022 (Batch #1)">AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 1 (01212022-1 to 01212022-14)</a> (PDF - 70MB) Posted December 2022</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="98c150ac-5a9b-482c-abe1-48939d40d771" href="/media/163569/download?attachment" title="AMA Testing of Official Samples of Talc Containing Cosmetics for Asbestiform Fibers - Assignment DFPG# 22-08, Batch No. 01212022 (Batch #2) ">AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 2&nbsp;(03022022-1 to 03022022-11)</a>&nbsp;(PDF - 61MB)&nbsp;Posted December 2022</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="5faf148e-37e0-42bf-8936-2210e0a44d11" href="/media/163570/download?attachment" title="AMA Testing of Official Samples of Talc Containing Cosmetics for Asbestiform Fibers - Assignment DFPG# 22-08, Batch No. 01212022 (Batch #3) ">AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 3 (03302022-1 to 03302022-13)</a>&nbsp;(PDF - 62MB)&nbsp;Posted December 2022</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="5d1f9613-5a3b-4a66-befa-455326450e0a" href="/media/163571/download?attachment" title="AMA Testing of Official Samples of Talc Containing Cosmetics for Asbestiform Fibers - Assignment DFPG# 22-08, Batch No. 01212022 (Batch #4) ">AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 4 (05022022-1 to 05022022-12)&nbsp;</a>(PDF - 57MB)&nbsp;Posted December 2022</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="14db5d06-2959-4c47-b872-919e957bc9f0" href="/media/159654/download?attachment" title="PFAS in Seafood Survey July 2022 Sample Brand Information">PFAS in Seafood Survey July 2022 Sample Brand Information</a> (PDF - 114KB) Posted July 2022</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="f61e4dba-8242-48fc-be27-8a97fd437a03" href="/media/158033/download?attachment" title="CFSAN-OFAS Bioactive Ingredients for Use In Infant Formula (Gras Notification 162 - Part 7)">CFSAN-OFAS Bioactive Ingredients for Use In Infant Formula (Gras Notification 162 - Part 7)</a>&nbsp;(PDF - 21MB) Posted April 2022</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="de245207-7bfb-4329-9e82-0fe56aa73f8b" href="/media/158034/download?attachment" title="CFSAN-OFAS Bioactive Ingredients for Use In Infant Formula (Gras Notification 189 - Part 7)">CFSAN-OFAS Bioactive Ingredients for Use In Infant Formula (Gras Notification 189 - Part 7)</a>&nbsp;(PDF - 37MB) Posted April 2022</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="a6d03e96-8dfc-4d28-9ca1-32967b9533f1" href="/media/158035/download?attachment" title="CFSAN-OFAS Bioactive Ingredients for Use In Infant Formula (Gras Notification 235 - Part 7)">CFSAN-OFAS Bioactive Ingredients for Use In Infant Formula (Gras Notification 235 - Part 7)</a>&nbsp;(PDF - 3MB) Posted April 2022</li> </ul> </div> </div> </div> <div title="Posted 2021" open="no" class=" panel panel-default fda-accordion-panel"> <div class="panel-heading" role="tab" id="heading_6746b94bb8d6f"> <h2 class="panel-title"> <a role="button" class="collapsed" data-toggle="collapse" data-parent href="#6746b94bb8d6f" aria-controls="6746b94bb8d6f">Posted 2021</a> </h2> </div> <div id="6746b94bb8d6f" class="panel-collapse collapse collapsed" role="tabpanel" aria-labelledby="heading_6746b94bb8d6f"> <div class="panel-body"> <ul> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="e90ed677-fdae-4360-bab5-859612dde696" href="/media/153397/download?attachment" title=" AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 1 (02282020-1 to 02282020-12)">AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 1 (02282020-1 to 02282020-12)</a> (PDF - 52MB) Posted October 2021</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="3c078bda-3c1d-429b-8a07-e5fbd1fc31d9" href="/media/153403/download?attachment" title="AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 2A (02232021-1 to 02232021-11)">AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 2A (02232021-1 to 02232021-11)</a>&nbsp;(PDF - 19MB) Posted October 2021</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="3c52abeb-936e-42bf-9454-600f11737573" href="/media/153404/download?attachment" title="AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 2B (02232021-12 to 02232021-13)">AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 2B (02232021-12 to 02232021-13)</a>&nbsp;(PDF - 2MB)&nbsp;Posted October 2021</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="cc97d99c-be00-488a-9906-e4bbb0bf946e" href="/media/153405/download?attachment" title="AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 3 (03242021-1 to 03242021-11)">AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 3 (03242021-1 to 03242021-11)</a>&nbsp;(PDF - 40MB) Posted October 2021</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="02c224c1-fcbf-4fd6-a2ec-e182cb9fbc52" href="/media/153406/download?attachment" title="AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 4 (04272021-1 to 04272021-14)">AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 4 (04272021-1 to 04272021-14)</a>&nbsp;(PDF - 65MB)&nbsp;Posted October 2021</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="3eeacc20-09a0-4ad9-ac63-aa8e835514a0" href="/media/152919/download?attachment" title="Food Allergens/Whole Foods Product Responsive Records re: CFSAN Warning letter (CFSAN FOI Reading Room Document) ">Food Allergens/Whole Foods Product Responsive Records re: CFSAN Warning letter</a> (PDF - 1MB) February 24, 2021</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="2d4fbc1f-48e5-49e0-bcbb-d3cbfc07952c" href="/media/151326/download?attachment" title="Letter to Manufacturers and Distributors of Fluorinated Polyethylene Food Contact Containers (August 5, 2021)">Letter to Manufacturers and Distributors of Fluorinated Polyethylene Food Contact Containers</a> (PDF - 250KB) August 5, 2021</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="616a83b0-3f29-472d-82cf-d9554e6b040b" href="/media/150371/download?attachment" title="Letter to Florida Fruit &amp; Vegetable Association as a Conduit to Growers, Harvesters, Packers, and Distributors of the St. Lucie Area Concerning Public Health Risk of Cyclospora cayetanenis (June 17, 2021)">Letter to Florida Fruit &amp; Vegetable Association as a Conduit to Growers, Harvesters, Packers, and Distributors of the St. Lucie Area Concerning the Public Health Risk of Cyclospora <em>cayetanensis</em></a>&nbsp;(PDF - 216KB) June 17, 2021</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="8a7e08da-332b-4742-b77f-79824205c625" href="/media/147481/download?attachment" title="Letter to BASF Agricultural Solutions About Low Levels of Genetic Material in Specific Lots of Canola Seed and Specific Canola Fields (April 2021)">Letter to BASF Agricultural Solutions About Low Levels of Genetic Material in Specific Lots of Canola Seed and Specific Canola Fields</a> (PDF - 84KB) April 13, 2021</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="34accaf1-6745-420a-b85b-ad53ba70ae82" href="/media/147482/download?attachment" title="Letter to Nuseed About Low Levels of Genetic Material in Specific Lots of Canola Seed and Specific Canola Fields (April 2021)">Letter to Nuseed About Low Levels of Genetic Material in Specific Lots of Canola Seed and Specific Canola Fields</a> (PDF - 63KB) April 13, 2021</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="bc902d1b-46a8-451e-8b0b-3545089e71ea" href="/media/146990/download?attachment" title="FDA Letter on Western Growers’ Collaborative Data Sharing Project (March 2021)">Letter to Western Growers Board of Directors and Members from Frank Yiannis</a> (PDF&nbsp;- 119KB) March 2, 2021</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="c883a6aa-bd46-4390-800f-81bc7df5c90e" href="/media/146423/download?attachment" title="Industry Letter to Baby and Toddler Food Manufacturers and Processors (March 2021)">Industry Letter to Baby and Toddler Food Manufacturers and Processors</a>&nbsp;(PDF - 176KB) March 5, 2021</li> </ul> </div> </div> </div> <div title="Posted 2020 " open="no" class=" panel panel-default fda-accordion-panel"> <div class="panel-heading" role="tab" id="heading_6746b94bb8e0a"> <h2 class="panel-title"> <a role="button" class="collapsed" data-toggle="collapse" data-parent href="#6746b94bb8e0a" aria-controls="6746b94bb8e0a">Posted 2020 </a> </h2> </div> <div id="6746b94bb8e0a" class="panel-collapse collapse collapsed" role="tabpanel" aria-labelledby="heading_6746b94bb8e0a"> <div class="panel-body"> <ul> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="1a55e107-ece3-4fa1-97b6-c35d8708df3b" href="/media/130853/download?attachment" title="GRN 000716 Meeting Summary: Bioactive Ingredients For Use In Infant Formula Part 1">CFSAN/OFAS Bioactive Ingredients for Use in Infant Formula Part 1</a> (PDF - 631KB)&nbsp;Posted September 2020</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="482e4eab-4ac9-453e-81c3-1bb6f6757250" href="/media/130854/download?attachment" title="GRN 000716 Meeting Summary: Bioactive Ingredients For Use In Infant Formula Part 2">CFSAN/OFAS Bioactive Ingredients for Use in Infant Formula Part 2</a> (PDF - 4MB)&nbsp;Posted September 2020</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="b7fbba65-09d0-4706-94bb-588daa4cab14" href="/media/130858/download?attachment" title="GRN 000716 Meeting Summary: Bioactive Ingredients For Use In Infant Formula Part 3">CFSAN/OFAS Bioactive Ingredients for Use in Infant Formula Part 3</a> (PDF - 3MB)&nbsp;Posted September 2020</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="5c081950-7188-482c-acc0-6ef74d46ba5e" href="/media/130856/download?attachment" title="GRN 000716 Meeting Summary: Bioactive Ingredients For Use In Infant Formula Part 4">CFSAN/OFAS Bioactive Ingredients for Use in Infant Formula Part 4 </a>(PDF - 3.9KB)&nbsp;Posted September 2020</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="90830efe-c1e2-4451-b691-2dd6a31282af" href="/media/130857/download?attachment" title="GRN 000716 Meeting Summary: Bioactive Ingredients For Use In Infant Formula Part 5">CFSAN/OFAS Bioactive Ingredients for Use in Infant Formula Part 5</a> (PDF - 2.4MB)&nbsp;Posted September 2020</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="cee64919-4674-4eb1-b8b6-4dc33bf4f918" href="/media/142048/download?attachment" title="GRN 000716 Meeting Summary: Bioactive Ingredients For Use In Infant Formula Part 6 - Glanbia Letter re use of bLf at Higher Levels">CFSAN/OFAS Bioactive Ingredients for Use in Infant Formula Part 6: Glanbia Letter re use of bLf at Higher Levels </a>(PDF - 59KB) March 3, 2020&nbsp;</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="a351b04e-d898-4769-92f7-62727ee93e7a" href="/media/142049/download?attachment" title="GRN 000716 Meeting Summary: Bioactive Ingredients For Use In Infant Formula Part 6 - Glanbia Bovine Lactoferrin in Infant Formula">CFSAN/OFAS Bioactive Ingredients for Use in Infant Formula Part 6: Glanbia Bovine Lactoferrin in Infant Formula </a>(PDF - 192KB) April 13, 2020</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="61477d8e-9e7a-4455-aabb-90ed034286a5" href="/media/139444/download?attachment" title="Second Letter to Papaya Growers, Harvesters, Packers, Distributors, Exporters, Importers, and Retailers Concerning Foodborne Illness Outbreaks Tied to Papayas ">Second Letter to Papaya Growers, Harvesters, Packers, Distributors, Exporters, Importers, and Retailers Concerning Foodborne Illness Outbreaks Tied to Papayas</a> (PDF - 106.9KB)&nbsp;June 25, 2020</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="783d20bb-98e7-493a-bc2a-8332dc012cc2" href="/media/138172/download?attachment" title="Letter to Industry Regarding the Memorandum of Understanding between FDA and USDA Regarding the Potential Use of the Defense Production Act with Regard to FDA-Regulated Food During the COVID-19 Pandemic ">Letter to Industry Regarding the Memorandum of Understanding between FDA and USDA Regarding the Potential Use of the Defense Production Act with Regard to FDA-Regulated Food During the COVID-19 Pandemic</a> (PDF - 63KB) May 18, 2020</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="64fac5a8-203f-4cfd-ba77-69399fdf8e05" href="/media/137707/download?attachment" title="Dr. Jockers COVID-19 Fraud Warning Letter - May 1, 2020">Dr. Jockers COVID-19 Fraud Warning Letter</a> (PDF - 120KB) May 1, 2020</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="1db47a61-ebb2-4b57-a093-f577e23a136e" href="/media/137291/download?attachment" title="South Mountain Creamery, LLC' s (SMC) FOIA Letter - April 2020">Letter to South Mountain Creamery</a> (PDF - 41KB) April 22, 2020 <ul> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="91c8bf5a-e2cb-4866-a0c0-c3372f937afd" href="/media/137292/download?attachment" title="South Mountain Creamery, LLC' s (SMC) FOIA Letter - July 2018">Letter to South Mountain Creamery (2018)</a>&nbsp;(PDF - 31KB) Posted April 2020</li> </ul> </li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="cb3ca30b-14a5-46b9-80a1-dc8d64d2aa44" href="/media/135901/download?attachment" title="AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 1 (D-30 to D-31)">AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 1 (D-30 to D-31)</a> (PDF –&nbsp;4.6 MB) Posted March 2020</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="9d937fd9-c3a9-46ff-9d2b-1c98a5c84061" href="/media/135902/download?attachment" title="AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 2 (D-32 to D-39)">AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 2 (D-32 to D-39)</a> (PDF –&nbsp;39.9 MB) Posted March 2020</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="48d1e177-f198-4e0c-b585-d8ddb039d1f4" href="/media/135905/download?attachment" title="AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 3 (D-40 to D-47, D-51 to D-52)">AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 3 (D-40 to D-47, D-51 to D-52)</a> (PDF – 56.7 MB) Posted March 2020</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="2002c5cb-6e66-4a9c-857b-85847a42ceb8" href="/media/135906/download?attachment" title="AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 4 (D-49 to D-50)">AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 4 (D-49 to D-50)</a> (PDF –&nbsp;33.5 MB) Posted March 2020</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="abfbc865-c38f-426b-958b-2f235a179275" href="/media/135908/download?attachment" title="AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 5 (D-53 to D-67)">AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 5 (D-53 to D-67)</a> (PDF –&nbsp;76.7 MB) Posted March 2020</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="898bef1c-8dd1-4395-adf7-6f291f36e5e3" href="/media/135909/download?attachment" title="AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 6 (D-68 to D-82)">AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Final Report Part 6 (D-68 to D-82)</a> (PDF –&nbsp;86.4 MB) Posted March 2020</li> </ul> </div> </div> </div> <div title="Posted 2019" open="no" class=" panel panel-default fda-accordion-panel"> <div class="panel-heading" role="tab" id="heading_6746b94bb8ec0"> <h2 class="panel-title"> <a role="button" class="collapsed" data-toggle="collapse" data-parent href="#6746b94bb8ec0" aria-controls="6746b94bb8ec0">Posted 2019</a> </h2> </div> <div id="6746b94bb8ec0" class="panel-collapse collapse collapsed" role="tabpanel" aria-labelledby="heading_6746b94bb8ec0"> <div class="panel-body"> <ul> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="3a5a0552-8f29-479e-8638-1d4ebcec3725" href="/media/131989/download?attachment" title="AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Johnson &amp; Johnson - Baby Powder Lot #22318RB - October 11 2019">AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis&nbsp;– Johnson &amp; Johnson – Baby Powder Lot #22318RB</a> (PDF - 7.68MB) October 3, 2019</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="bd37d8e3-1fe5-4371-a059-ab1d3ba087cf" href="/media/135497/download?attachment" title="Johnson &amp; Johnson Testing FOIA 2019 Request Final Combined Responsive Records ">Johnson &amp; Johnson Testing FOIA 2019 Request Final Combined Responsive Records (Redacted)</a> (PDF - 18MB) October 25, 2019</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="3d5a689d-bd33-4793-b081-ba9ac5a85077" href="/media/135498/download?attachment" title="AMA Analysis of Official Samples: Report for Sample D 58, Asbestos Fibers in Talc (Submitted 7/24/2019)">AMA Final Report for Sample D 58</a>&nbsp;(PDF - 6MB) October 3, 2019</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="969eeb76-a338-4b2a-a806-c41e8515b5f7" href="/media/130565/download?attachment" title="AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Beauty Plus – Timeless Beauty Palette (Submitted 5/29/2019)">AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Beauty Plus – Timeless Beauty Palette</a> (PDF - 8MB) Posted August 2019</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="4ad4a74a-14d5-41b0-a736-4396ed38292b" href="/media/130566/download?attachment" title="AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Beauty Plus – Matte Blush in Fuchsia (Submitted 5/29/2019)">AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Beauty Plus – Matte Blush in Fuchsia</a> (PDF - 8MB) Posted August 2019</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="b08d3b4d-8e01-4c6c-b340-e9cd8402a622" href="/media/130567/download?attachment" title="AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Beauty Plus – Shimmer Bronzer in Caramel (Submitted 5/23/2019)">AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Beauty Plus – Shimmer Bronzer in Caramel</a> (PDF - 5MB) Posted August 2019</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="7309608b-c791-4211-a3f4-8245a22c8967" href="/media/130568/download?attachment" title="AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Beauty Plus – Bronzer in Sunset (Submitted 5/23/2019)">AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Beauty Plus – Bronzer in Sunset</a> (PDF - 7MB) Posted August 2019</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="0337d655-1a2a-4c5b-8643-93d8f4c0b13b" href="/media/130271/download?attachment" title="Letter to Papaya Growers, Harvesters, Packers, Distributors, Exporters, Importers, and Retailers Concerning Foodborne Illness Outbreaks Tied to Papayas dated August 26, 2018">Letter to Papaya Growers, Harvesters, Packers, Distributors, Exporters, Importers, and Retailers Concerning Foodborne Illness Outbreaks Tied to Papayas </a>August 26, 2019</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="827e9205-232f-4322-9cae-3b1ee5fd764e" href="/media/130229/download?attachment" title="FDA Response to American Frozen Food Institute August 8, 2019">Letter from Deputy Commissioner Frank Yiannas to the American Frozen Food Institute Regarding the FDA’s Microbiological Sampling Assignment for Frozen Berries</a> (PDF - 903KB)&nbsp;August 8, 2019</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="40356f97-e241-4932-8d12-9a0ae0b20b48" href="/media/129654/download?attachment" title="Letter from Deputy Commissioner Frank Yiannas to Washington Red Raspberry Commission, Oregon Raspberry &amp; Blackberry Commission, and Oregon Strawberry Commission">Letter from Deputy Commissioner Frank Yiannas to Washington Red Raspberry Commission, Oregon Raspberry &amp; Blackberry Commission, and Oregon Strawberry Commission</a> (PDF - 34KB) July 24, 2019</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="225a6f80-ce65-4f38-8dcc-e9ae21839162" href="/media/129655/download?attachment" title="Letter from Deputy Commissioner Frank Yiannas to the American Frozen Food Institute July 24, 2019">Letter from Deputy Commissioner Frank Yiannas to the American Frozen Food Institute</a> (PDF - 66KB) July 24, 2019</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="bd49977a-eb5d-46b4-802f-ff2bdce4e9b3" href="/media/127824/download?attachment" title="AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Beauty Plus (Submitted 3/14/2019)">AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Beauty Plus</a> (PDF - 11MB) Posted 2019</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="5b8edf6f-3151-4f54-a80a-bdbde8bd2262" href="/media/127825/download?attachment" title="AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Claire’s (Submitted 3/14/2019)">AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis – Claire’s</a> (PDF - 2MB) Posted 2019</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="ae7b702f-6fe3-4d38-91d7-e318e2b156b4" href="/media/127632/download?attachment" title="Deputy Commissioner Frank Yiannas Letter to NASDA">Letter from Deputy Commissioner Frank Yiannas to NASDA</a> (PDF - 174KB) June 6, 2019</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="91fb94a7-0585-4d0f-a6b0-29a57f4ddea9" href="/media/125114/download?attachment" title="Deputy Comissioner Frank Yiannas Letter to Food Industry">Letter from Deputy Commissioner Frank Yiannas to the Food Industry</a> (PDF - 144KB) May 23, 2019&nbsp;</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="0fe7c56c-1a49-4d68-ad66-6105c6bf3396" href="/media/122413/download?attachment" title="OSHA Evaluation of Cosmetics and Cosmetic Talc for FDA ">OSHA Evaluation of Cosmetics and Cosmetic Talc for FDA</a>&nbsp;(PDF - 2.6MB)&nbsp;February 23, 2019</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="ca9a5d96-ac48-4381-959d-5ada499e7c24" href="/media/122414/download?attachment" title="AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis (Submitted 11/14/2018)">AMA Analytical Services, Inc. Summary of Asbestos and Talc Analysis&nbsp;</a>(PDF - 3.9MB) February 21, 2019</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="17afdab6-0eb4-49bc-a0af-e7dd97679ec9" href="/media/120151/download?attachment" title="Letter from Commissioner Gottlieb to National Association of State Departments of Agriculture on Produce Safety Resources 2019 ">Letter from Commissioner Gottlieb to National Association of State Departments of Agriculture on Produce Safety Resources 2019&nbsp;</a>(PDF - 135KB)&nbsp;February 7, 2019</li> </ul> </div> </div> </div> <div title="Posted 2018 - 2016 " open="no" class=" panel panel-default fda-accordion-panel"> <div class="panel-heading" role="tab" id="heading_6746b94bb8f7f"> <h2 class="panel-title"> <a role="button" class="collapsed" data-toggle="collapse" data-parent href="#6746b94bb8f7f" aria-controls="6746b94bb8f7f">Posted 2018 - 2016 </a> </h2> </div> <div id="6746b94bb8f7f" class="panel-collapse collapse collapsed" role="tabpanel" aria-labelledby="heading_6746b94bb8f7f"> <div class="panel-body"> <ul> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="8b91d004-5d31-4078-9a8c-de49d7963a31" href="/media/123344/download?attachment" title="JIFSAN Symposium Asbestos in Talc Main Session Transcript from November 28, 2018">JIFSAN Symposium Asbestos in Talc Main Session Transcript</a>&nbsp;(PDF - 1.1MB)&nbsp;November 28, 2018</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="5ba86f34-5f37-4ad1-afad-cb6acf7fac8a" href="/media/123392/download?attachment" title="JIFSAN Symposium Asbestos in Talc Breakout Session A from November 20, 2018">JIFSAN Symposium Asbestos in Talc Breakout Session A Transcript</a>&nbsp;(PDF - 490KB)&nbsp;November 28, 2018</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="bc45c108-5cc7-4616-927d-66e7acce892e" href="/media/123393/download?attachment" title="JIFSAN Symposium Asbestos in Talc Breakout Session B from November 28, 2018">JIFSAN Symposium Asbestos in Talc Breakout Session B Transcript</a>&nbsp;PDF - 292KB)&nbsp;November 28, 2018</li> <li><a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="cb0ff23c-6bc4-4861-81cc-0c78d21544cd" href="/media/123394/download?attachment" title="JIFSAN Symposium Asbestos in Talc Breakout Session C from November 28, 2018">JIFSAN Symposium Asbestos in Talc Breakout Session C Transcript</a>&nbsp;(PDF - 397KB)&nbsp;November 28, 2018</li> <li><a href="https://wayback.archive-it.org/7993/20190206201101/https:/www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofFoods/CFSAN/CFSANFOIAElectronicReadingRoom/UCM624797.pdf">Letter to State Agriculture Officials and the Leafy Greens Industry Concerning Environmental Assessment of Factors Potentially Contributing to the Contamination of Romaine Lettuce Implicated in a Multi-State Outbreak of E. coli O157:H7</a>&nbsp;(PDF - 120KB)&nbsp;November 1, 2018</li> <li><a href="https://wayback.archive-it.org/7993/20190206201101/https:/www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofFoods/CFSAN/CFSANFOIAElectronicReadingRoom/UCM618981.pdf">Letter to California EPA Concerning Proposed Adoption of 27 Cal. Code. Reg. § 25704 – Exposures to Proposition 65 Listed Chemicals in Coffee Posing No Significant Risk of Cancer</a>&nbsp;(PDF - 223KB)&nbsp;August 29, 2018</li> <li><a href="https://wayback.archive-it.org/7993/20190206201101/https:/www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofGlobalRegulatoryOperationsandPolicy/ORA/ORAElectronicReadingRoom/UCM603489.pdf">Mandatory Recall Order sent to Triangle Pharmanaturals LLC Concerning Products Containing Powdered Kratom</a>&nbsp;(PDF - 508KB)&nbsp;April 2, 2018</li> <li><a href="https://wayback.archive-it.org/7993/20190206201101/https:/www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofGlobalRegulatoryOperationsandPolicy/ORA/ORAElectronicReadingRoom/UCM603488.pdf">Prehearing Order to Cease Distribution and Give Notice sent to Triangle Pharmanaturals LLC Concerning Products Containing Powdered Kratom</a>&nbsp;(PDF - 998KB)&nbsp;March 31, 2018</li> <li><a href="https://wayback.archive-it.org/7993/20190206201101/https:/www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofGlobalRegulatoryOperationsandPolicy/ORA/ORAElectronicReadingRoom/UCM603487.pdf">Notification of Opportunity to Initiate a Voluntary Recall sent to Triangle Pharmanaturals LLC Concerning Products Containing Powdered Kratom</a>&nbsp;(PDF - 1.3MB)&nbsp;March 30, 2018</li> <li><a href="https://wayback.archive-it.org/7993/20190206201101/https:/www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofFoods/CFSAN/CFSANFOIAElectronicReadingRoom/UCM601347.pdf">Letter in Response to Correspondence over Winegrapes and the FSMA Produce Rule</a>&nbsp;(PDF - 65KB)&nbsp;March 15, 2018</li> <li><a href="https://wayback.archive-it.org/7993/20190206201101/https:/www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofFoods/CFSAN/CFSANFOIAElectronicReadingRoom/UCM598251.pdf">FDA Letter to Industrial Chemicals LLC and INI Botanicals Regarding Mitrasafe (mitragynine extract)</a>&nbsp;(PDF - 82KB)&nbsp;February 26, 2018</li> <li><a href="https://wayback.archive-it.org/7993/20190206201101/https:/www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofFoods/CFSAN/CFSANFOIAElectronicReadingRoom/UCM588952.pdf">CFSAN Adverse Event Reporting System: Kratom Deaths (December 1, 2017)</a>&nbsp;(PDF - 1.9MB)&nbsp;December 1, 2017</li> <li><a href="https://wayback.archive-it.org/7993/20190206201101/https:/www.fda.gov/downloads/Food/InternationalInteragencyCoordination/InternationalCooperation/UCM578577.pdf">FDA Comments to the USDA’s Request for Information on Reorganization Actions, Including the Codex Move</a>&nbsp;(PDF - 1.8MB)&nbsp;October 3, 2017</li> <li><a href="https://wayback.archive-it.org/7993/20190206201101/https:/www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofFoods/CFSAN/CFSANFOIAElectronicReadingRoom/UCM549757.pdf">Suspension of Food Facility Registration Order to Dixie Dew Products, Inc.</a>&nbsp;(PDF - 3.6MB)&nbsp;March 27, 2017</li> <li><a href="https://wayback.archive-it.org/7993/20190206201101/https:/www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofFoods/CFSAN/CFSANFOIAElectronicReadingRoom/UCM521045.pdf">Suspension Order of Food Facility Registration to SM Fish Corp.</a>&nbsp;(PDF - 97KB)&nbsp;September 13, 2016</li> </ul> </div> </div> </div> </div> </div> <p>&nbsp;</p> <p>&nbsp;</p> <br> <div class="sub-section-paragraph"></div> <br> </div> <aside class="col-md-2 col-md-push-2" role="complementary"> <section id="block-entityviewcontent-4" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix"> <div class="region region-"> <aside class="lcds-card lcds-card--border-top" > <ul role="menu" class="lcds-description-list"> <li role="menuitem" class="node-current-date lcds-description-list__item"> <div> <h2 class="lcds-description-list__item-heading">Content current as of:</h2> <p class="lcds-description-list__item-text"><time datetime="2024-10-01T10:00:00Z">10/01/2024</time> </p> </div> </li> <li role="menuitem" class="lcds-description-list__item"> <div> <h2 class="lcds-description-list__item-heading">Regulated Product(s)</h2> <ul role="menu" class="lcds-metadata-list"> <li role="menuitem">Dietary Supplements</li> <li role="menuitem">Food &amp; Beverages</li> </ul> </div> </li> </ul> </aside> </div> </section> </aside> <aside class="col-md-2 col-md-pull-10" role="complementary"> <section id="block-entityviewcontent-3" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix"> <div class="region region-"> <nav id="section-nav" class="lcds-card lcds-section-nav lcds-section-nav--side hidden-xs hidden-sm"> <ul class="lcds-section-nav__list lcds-section-nav--side__list"> <li> <a href="/about-fda/human-foods-program/hfp-foia-electronic-reading-room" class="lcds-section-nav__link lcds-section-nav--side__link lcds-section-nav__parent-link lcds-section-nav--side__parent-link">HFP FOIA Electronic Reading Room</a> <div class="views-element-container form-group"><div class="view view-in-this-section view-id-in_this_section view-display-id-block_4 js-view-dom-id-c0695b9666c138e3967822a2bc1f44cac81a34cd68b1f48bfe263284df81d903"> </div> </div> <div class="views-element-container form-group"><div class="view view-in-this-section-sub view-id-in_this_section_sub view-display-id-block_1 js-view-dom-id-9e41184410de75b1a98b55d32538d6d7e74128f7229df2c78c69fc828a534896"> </div> </div> </li> </ul> </nav> </div> </section> </aside> </article> </main> </div> </div> <div class="region region-subscribe"> <section id="block-entityviewcontent-5" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix"> </section> </div> <footer class="lcds-footer container-fluid"> <div class="row lcds-footer__primary"> <h2 id="footer-heading" class="sr-only">Footer Links</h2> <nav class="text-center"> <div class="col-sm-4"> <ul class="nav"> <li><a href="/about-fda/about-website/fdagov-archive" >FDA Archive</a></li> <li><a href="/about-fda" >About FDA</a></li> <li><a href="/about-fda/about-website/internet-accessibility" >Accessibility</a></li> </ul> </div> <div class="col-sm-4"> <ul class="nav"> <li><a href="/about-fda/visitor-information" >Visitor Information</a> </li> <li><a href="/about-fda/about-website/website-policies" >Website Policies / Privacy</a></li> <li><a href="/about-fda/jobs-and-training-fda/no-fear-act" >No FEAR Act</a></li> <li><a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" >Vulnerability Disclosure Policy</a></li> </ul> </div> <div class="col-sm-4"> <ul class="nav"> <li><a href="/regulatory-information/freedom-information" title="Freedom of Information Act">FOIA</a></li> <li><a href="https://www.hhs.gov/" title="Health and Human Services" target="_blank">HHS.gov</a></li> <li><a href="https://www.usa.gov/" target="_blank">USA.gov</a></li> </ul> </div> </nav> </div> <div class="row lcds-footer__secondary"> <div class="col-sm-12 col-md-6 col-lg-4 lcds-footer__social-links"> <a href="/about-fda/contact-fda" class="btn btn-default btn-md">Contact FDA</a> <a href="https://www.facebook.com/FDA" title="Follow FDA on Facebook" class="no-disclaimer"> <span class="fa fa-facebook fa-2x" aria-hidden="true"> <span class="sr-only">Follow FDA on Facebook</span> </span> </a> <a href="https://x.com/US_FDA" title="Follow FDA on X" class="no-disclaimer"> <svg class="icon-svg-inline fa-2x" aria-hidden="true"> <use href="/themes/custom/preview/assets/images/fa-icons.svg#icon-x-twitter"> </svg> <span class="sr-only">Follow FDA on X</span> </a> <a href="https://instagram.com/FDA" title="Follow FDA on Instagram" class="no-disclaimer"> <span class="fa fa-instagram fa-2x" aria-hidden="true"> <span class="sr-only">Follow FDA on Instagram</span> </span> </a> <br class='visible-xs-inline'/> <a href="https://www.linkedin.com/company/fda/" title="Follow FDA on LinkedIn" class="no-disclaimer"> <span class="fa fa-linkedin fa-2x" aria-hidden="true"> <span class="sr-only">Follow FDA on LinkedIn</span> </span> </a> <a href="https://youtube.com/@US_FDA" title="View FDA videos on YouTube" class="no-disclaimer"> <span class="fa fa-youtube fa-2x" aria-hidden="true"> <span class="sr-only">View FDA videos on YouTube</span> </span> </a> <a href="/about-fda/contact-fda/subscribe-podcasts-and-news-feeds" title="Subscribe to FDA RSS feeds"> <span class="fa fa-rss fa-2x" aria-hidden="true"> <span class="sr-only">Subscribe to FDA RSS feeds</span> </span> </a> </div> <a href="/" title="FDA Homepage"> <div class="visible-lg-block col-lg-4 text-center lcds-footer__logo"> <span class="sr-only">FDA Homepage</span> </div> </a> <div class="col-sm-12 col-md-6 col-lg-4 text-center lcds-footer__contact-number"> <span class="fa fa-phone" aria-hidden="true"> </span> <span class="sr-only">Contact Number</span> 1-888-INFO-FDA (1-888-463-6332) </div> </div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <a href="" id="btn-top" class="btn btn-primary btn-top"><span class="sr-only">Back to </span>Top</a> </div> <script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","pathPrefix":"","currentPath":"node\/359629","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"fda_ckeditor_enhancements":{"basePath":"modules\/custom\/fda_ckeditor_enhancements"},"google_analytics":{"account":"G-273DTKB5QW","trackOutbound":true,"trackMailto":true,"trackTel":true,"trackDownload":true,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip"},"bootstrap":{"forms_has_error_value_toggle":1,"modal_animation":1,"modal_backdrop":"true","modal_focus_input":1,"modal_keyboard":1,"modal_select_text":1,"modal_show":1,"modal_size":"","popover_enabled":1,"popover_animation":1,"popover_auto_close":1,"popover_container":"body","popover_content":"","popover_delay":"0","popover_html":0,"popover_placement":"right","popover_selector":"","popover_title":"","popover_trigger":"click"},"ajax":[],"user":{"uid":0,"permissionsHash":"3aef67b4ac7d861d8624bf1f7ab2bc9cfc56d3c25b7d709dc15466dfa996dfb0"}}</script> <script src="/files/js/js_jmx6639WuKcEs1DgFSmm8g__5ByGF4YtLnPWvZO-XrM.js?scope=footer&amp;delta=0&amp;language=en&amp;theme=preview&amp;include=eJxljlEOwjAMQy_UUX6QuE2VtVmpaOuqCUPj9DAQA8FP5NiS_SZUpSsLCtvpo3cmAjGzo0p50eTF_hpGFlEudiRh0zrPia82ZoyUB9Elpxr_bN9TUzEjoKKdmm1omLmbKZDzZw5J0R3XE1XPhauKJe_RQ0J1irgCyAldPQKbtVrs8-4KwiXzqwel5bQ2vDJ32B-_TDM91iuUxW5qA_WdbgvHD3mg9tx6_9v6sIHdAfkmf6A"></script> <script type="text/javascript" src="/Dc2Go5/dCelR/Sewog/rk5-/5VYNNfD46DcX/DQdKdDY/XS/EsHSMaAwQB"></script></body> </html>

Pages: 1 2 3 4 5 6 7 8 9 10